NCT02115581View on ClinicalTrials.gov

Coenzyme Q10 Supplementation in Children With Idiopathic Dilated Cardiomyopathy

PHASE4CompletedINTERVENTIONAL
Enrollment

38

Participants

Timeline

Start Date

September 30, 2006

Primary Completion Date

March 31, 2008

Study Completion Date

March 31, 2008

Conditions
Dilated Cardiomyopathy
Interventions
DRUG

Coenzyme Q10

dose of 2 mg/kg/day in 2 or 3 divided doses and increased to the maximum dose of 10 mg/kg/day according to the patient's tolerance

DRUG

Placebo

dose of 2 mg/kg/day in 2 or 3 divided doses and increased to the maximum dose of 10 mg/kg/day according to the patient's tolerance

Trial Locations (1)

14194

Children's Medical Center, Tehran

All Listed Sponsors
lead

University of Tehran

OTHER

NCT02115581 - Coenzyme Q10 Supplementation in Children With Idiopathic Dilated Cardiomyopathy | Biotech Hunter | Biotech Hunter